Circulating Osteoprotegerin in Chronic Kidney Disease and All-Cause Mortality

Joanna Kamińska1, Marek Stopiński1, Krzysztof Mucha2,3

  • 1Department of Internal Diseases and Dialysis Unit, West Hospital of Saint John Paul II, Grodzisk Mazowiecki, Poland.

Insights

Osteoprotegerin (OPG) levels predict mortality in chronic kidney disease (CKD) patients. Measuring OPG, potentially with coronary calcium score, can help stratify mortality risk in CKD stages 3-4 and end-stage renal disease.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Chronic kidney disease (CKD) is linked to cardiovascular disease, mineral and bone disorder, and increased mortality.
  • Bone-related factors like osteopontin (OPN), osteocalcin (OC), osteoprotegerin (OPG), and fibroblast growth factor 23 (FGF23) are implicated in CKD's cardiovascular complications.
  • These factors may hold predictive value for mortality in CKD patients.

Purpose of the Study:

  • To investigate the relationship between OPN, OC, OPG, and FGF23 with clinical characteristics in CKD patients.
  • To assess the predictive ability of these bone-related factors for mortality across different stages of CKD.

Main Methods:

  • Study groups included end-stage renal disease (ESRD) (38), CKD stages 3-4 (19), and non-CKD controls (19).
  • Serum concentrations of OPN, OC, OPG, and FGF23 were measured from a single blood draw.
  • Coronary calcium score (CS) was evaluated using cardiac computed tomography, and patients were followed for 5-year all-cause mortality.

Main Results:

  • Serum OPN, OC, and OPG levels significantly increased with CKD progression and were positively correlated.
  • OPN and OPG showed significant positive correlations with coronary calcium score.
  • Serum OPG demonstrated the strongest association with declining GFR and predicted increased mortality risk in CKD3-4 and ESRD patients (HR 5.8).

Conclusions:

  • A single measurement of osteoprotegerin is associated with 5-year all-cause mortality in patients with CKD stages 3-4 or ESRD.
  • Assessing OPG concentration, ideally combined with coronary calcium score, is suggested for stratifying mortality risk in CKD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
215
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.5K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
297
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
162
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
39.0K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
432